1 Department of Pharm D, CMR College of Pharmacy, Hyderabad, India.
2 Department of Pharmaceutical Sciences, CMR college of Pharmacy, Hyderabad, India.
International Journal of Science and Research Archive, 2025, 15(03), 688-699
Article DOI: 10.30574/ijsra.2025.15.3.1451
Received on 11 April 2025; revised on 21 May 2025; accepted on 23 May 2025
A progressive illness, chronic kidney disease (CKD) is linked to several systemic consequences that raise morbidity and death. Anemia, fluid retention, renal osteodystrophy, cardiovascular disease (CVD), and sepsis are the main consequences of chronic kidney disease (CKD) that are highlighted in this study. Iron dysregulation and decreased erythropoietin production cause anemia, but water and sodium retention cause fluid overload. Unbalances in the metabolism of calcium, phosphate, and vitamin D are the main cause of renal osteodystrophy. Both conventional and CKD-specific risk factors contribute to CVD, the primary cause of death in CKD patients. Because of immunological failure, CKD also makes people more vulnerable to infections and sepsis. To enhance patient outcomes, early detection and focused therapy approaches—such as phosphate binders, erythropoiesis-stimulating medicines, and new drugs like SGLT2 inhibitors and HIF-PHIs—are crucial.
Chronic Kidney Disease; Anemia; Fluid Retention; Renal Osteodystrophy; Hyperparathyroidism; Cardiovascular Disease; Sepsis.
Preview Article PDF
Vankodoth Sireesha, Bhavani Dhomakonda, Mekala Sai Charitha, Gadila Sushma, Boddu Shirisha and T. Rama Rao. Understanding and managing the complications of chronic kidney disease: A comprehensive review. International Journal of Science and Research Archive, 2025, 15(03), 688-699. Article DOI: https://doi.org/10.30574/ijsra.2025.15.3.1451.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0







